|
NAF1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.158300E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.246020E-01 |
| Normal-vs-Stage2 |
7.665500E-02 |
| Normal-vs-Stage3 |
2.25480000226597E-08 |
| Normal-vs-Stage4 |
5.04049999516809E-08 |
| Stage1-vs-Stage2 |
3.468000E-01 |
| Stage1-vs-Stage3 |
2.53429999985677E-07 |
| Stage1-vs-Stage4 |
1.63009999998298E-06 |
| Stage2-vs-Stage3 |
4.376300E-02 |
| Stage2-vs-Stage4 |
3.212000E-02 |
| Stage3-vs-Stage4 |
7.389600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.50390000000545E-05 |
| Normal-vs-AfricanAmerican |
9.683800E-02 |
| Normal-vs-Asian |
2.182200E-01 |
| Caucasian-vs-AfricanAmerican |
3.945400E-01 |
| Caucasian-vs-Asian |
8.633400E-01 |
| AfricanAmerican-vs-Asian |
8.858400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.82283999999866E-05 |
| Normal-vs-Female |
1.863600E-02 |
| Male-vs-Female |
3.668400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.155600E-03 |
| Normal-vs-Age(41-60Yrs) |
3.983700E-03 |
| Normal-vs-Age(61-80Yrs) |
9.67570000000029E-05 |
| Normal-vs-Age(81-100Yrs) |
1.344230E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.405000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.362400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.079400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.586600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.781780E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.098200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.480600E-01 |
| Normal-vs-Grade 2 |
2.737600E-01 |
| Normal-vs-Grade 3 |
5.37979999992722E-07 |
| Normal-vs-Grade 4 |
1.05000452776949E-11 |
| Grade 1-vs-Grade 2 |
1.844030E-01 |
| Grade 1-vs-Grade 3 |
4.764100E-04 |
| Grade 1-vs-Grade 4 |
6.97669999993877E-07 |
| Grade 2-vs-Grade 3 |
1.0370999999898E-06 |
| Grade 2-vs-Grade 4 |
2.17089679566129E-11 |
| Grade 3-vs-Grade 4 |
9.211200E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.497800E-01 |
| Normal-vs-ccB subtype |
2.01140000000155E-06 |
| ccA subtype-vs-ccB subtype |
2.20509999999674E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.638430E-04 |
| Normal-vs-N1 |
1.570160E-04 |
| N0-vs-N1 |
7.515600E-02 |
|
|
